

Senegal stopped mass drug administration (MDA) for lymphatic filariasis in 80% of endemic health districts (HDs); 41 out of 51 HDs as of FY22 (October 2021 – September 2022).

All trachoma-endemic health districts have achieved trachomatous inflammation follicular (TF) rate of less than 5% among children ages 1-9 years, and have achieved the stop-MDA threshold as of FY 2018. In addition, all these districts have sustained TF below 5% during trachoma surveillance surveys.

The National Onchocerciasis Elimination Committee decided to stop MDA in all 8 endemic districts following a successful epidemiological and entomological impact assessment in FY22 (October 2021 – September 2022).

Following the successful implementation of over five rounds of effective (>75% coverage) MDA, Senegal conducted a schistosomiasis/soil-transmitted helminthiasis (SCH/STH) impact assessment in eight districts in 2022. Another 4 districts have been approved to conduct more impact assessments in 2023. Data from these surveys will enable Senegal to consider a more focal sub-district MDA in 2023.
Standard Disease-Specific Indicators as of FY21
FY21 is October 2020 through September 2021

of ever-endemic districts have stopped MDA as of FY21
(i.e. have passed stop MDA survey, TAS1 (First Transmission Assessment Survey))
No ever-endemic districts in post-surveillance phase as of FY21
(i.e. have passed last surveillance survey, TAS3 (third Transmission Assessment Survey))
of persons no longer at risk as of FY21 among those who were ever at risk

of ever-endemic districts have stopped MDA as of FY21
(i.e. have passed stop MDA survey, TIS (Trachoma Impact Survey))*
*MDA has stopped for Trachoma in all districts
of ever-endemic districts in post-MDA surveillance phase as of FY21
(i.e. have passed surveillance survey, TSS (Trachoma Surveillance Survey))
of persons no longer at risk as of FY21 among those who were ever at risk

of ever endemic districts have been treated at least once as of FY21
(in cases where a country has more treated districts reported than, ever endemic, the adjusted percent is 100%)

of ever endemic districts have been treated at least once as of FY21
